Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Monday, September 30, 2024.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2024 (2024-09-30): -468.81%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-188.07%
RETURN ON EQUITY (ROE) AVG 3Y
-37.53%
RETURN ON EQUITY (ROE) AVG 5Y
-46.54%
RETURN ON EQUITY (ROE) AVG 10Y
-81.14%
RETURN ON EQUITY (ROE) AVG 15Y
-70.43%
RETURN ON EQUITY (ROE) AVG 20Y
-60.76%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Avita Medical Inc.
Market Cap
$319.65M
Return on Equity (ROE)
N/A
TTM Avg
-188.07%
3Y Avg
-37.53%
5Y Avg
-46.54%
Market Cap
$320.59M
Return on Equity (ROE)
-320.77%
TTM Avg
-82.83%
3Y Avg
-78.63%
5Y Avg
-104.90%
Market Cap
$318.98M
Return on Equity (ROE)
N/A
TTM Avg
34.79%
3Y Avg
145.50%
5Y Avg
100.23%
Market Cap
$321.85M
Return on Equity (ROE)
-403.03%
TTM Avg
-329.00%
3Y Avg
-171.64%
5Y Avg
-130.54%
Market Cap
$321.48M
Return on Equity (ROE)
-86.10%
TTM Avg
-112.93%
3Y Avg
-76.30%
5Y Avg
-62.48%
Market Cap
$324.92M
Return on Equity (ROE)
-226.56%
TTM Avg
-87.78%
3Y Avg
-55.09%
5Y Avg
-55.09%
Market Cap
$314.56M
Return on Equity (ROE)
-41.02%
TTM Avg
-44.84%
3Y Avg
-46.96%
5Y Avg
-38.83%
Market Cap
$302.32M
Return on Equity (ROE)
-25.73%
TTM Avg
-32.35%
3Y Avg
-2448.72%
5Y Avg
-1749.34%
Market Cap
$301.90M
Return on Equity (ROE)
N/A
TTM Avg
30.84%
3Y Avg
30.84%
5Y Avg
30.84%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avita Medical Inc. (RCEL) | $319.65M | N/A | -188.07% | -37.53% | -46.54% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $320.59M | -320.77% | -82.83% | -78.63% | -104.90% |
| Agenus Inc. (AGEN)vs › | $318.98M | N/A | 34.79% | 145.50% | 100.23% |
| Sanara MedTech Inc. (SMTI)vs › | $321.85M | -403.03% | -329.00% | -171.64% | -130.54% |
| Cabaletta Bio, Inc. (CABA)vs › | $321.48M | -86.10% | -112.93% | -76.30% | -62.48% |
| CapsoVision, Inc. (CV)vs › | $324.92M | -226.56% | -87.78% | -55.09% | -55.09% |
| C4 Therapeutics, Inc. (CCCC)vs › | $314.56M | -41.02% | -44.84% | -46.96% | -38.83% |
| Benitec Biopharma Inc. (BNTC)vs › | $302.32M | -25.73% | -32.35% | -2448.72% | -1749.34% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $301.90M | N/A | 30.84% | 30.84% | 30.84% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.27M | -29.98% | -145.74% | -129.76% | -105.96% |
ROE
N/A
ROA
-90.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2024-09-30 | -468.81% |
| 2024-06-30 | -208.35% |
| 2024-03-31 | -137.61% |
| 2023-12-31 | -72.12% |
| 2023-09-30 | -53.46% |
| 2023-06-30 | -44.50% |
| 2023-03-31 | -34.07% |
| 2022-12-31 | -31.47% |
| 2022-09-30 | -33.86% |
| 2022-06-30 | -32.57% |
| 2022-03-31 | -29.25% |
| 2021-12-31 | -24.03% |
| 2021-09-30 | -20.01% |
| 2021-06-30 | -22.98% |
| 2021-03-31 | -29.24% |
| 2020-12-31 | -73.80% |
| 2020-09-30 | -74.53% |
| 2020-06-30 | -60.60% |
| 2020-03-31 | -43.23% |
| 2019-12-31 | -41.35% |
| 2019-09-30 | -116.69% |
| 2019-06-30 | -82.87% |
| 2019-03-31 | -103.78% |
| 2018-12-31 | -63.74% |
| 2018-09-30 | -70.99% |
| 2018-06-30 | -69.31% |
| 2018-03-31 | -81.79% |
| 2017-12-31 | -74.90% |
| 2017-09-30 | -86.37% |
| 2017-06-30 | -169.67% |
| 2017-03-31 | -181.77% |
| 2016-12-31 | -51.11% |
| 2016-09-30 | -68.53% |
| 2016-06-30 | -82.93% |
| 2016-03-31 | -115.08% |
| 2015-12-31 | -73.70% |
| 2015-09-30 | -97.29% |
| 2015-06-30 | -132.68% |
| 2015-03-31 | -158.11% |
| 2014-12-31 | -215.99% |
| 2014-09-30 | -234.99% |
| 2014-06-30 | -82.55% |
| 2014-03-31 | -110.18% |
| 2013-12-31 | -108.07% |
| 2013-09-30 | -114.22% |
| 2013-06-30 | -78.04% |
| 2013-03-31 | -81.76% |
| 2012-12-31 | -63.80% |
| 2012-09-30 | -50.65% |
| 2012-06-30 | -63.18% |
| 2012-03-31 | -31.86% |
| 2011-12-31 | 0.00% |
| 2011-06-30 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-06-30 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-06-30 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-06-30 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-06-30 | 0.00% |
| 2005-12-31 | 0.00% |
